245 related articles for article (PubMed ID: 33068489)
1. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
[TBL] [Abstract][Full Text] [Related]
2. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
[TBL] [Abstract][Full Text] [Related]
3. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
[TBL] [Abstract][Full Text] [Related]
4. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
5. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
6. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
Maclean W; Mackenzie P; Limb C; Zahoor Z; Whyte MB; Rockall T; Benton SC; Jourdan I
Colorectal Dis; 2021 Sep; 23(9):2376-2386. PubMed ID: 34157205
[TBL] [Abstract][Full Text] [Related]
8. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
[TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
[TBL] [Abstract][Full Text] [Related]
10. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
[TBL] [Abstract][Full Text] [Related]
11. An observational study of replicate faecal immunochemical tests in the urgently referred symptomatic cohort.
Farkas NG; O'Brien J; Whyte M; Jourdan I; Rockall T; Benton SC
Ann Clin Biochem; 2023 Sep; 60(5):313-319. PubMed ID: 36864586
[TBL] [Abstract][Full Text] [Related]
12. Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
Lincoln AG; Benton SC; Piggott C; Sheikh SR; Beggs AD; Buckley L; DeSouza B; East JE; Sanders P; Lim M; Sheehan D; Snape K; Hanson H; Greenaway JR; Burn J; Nylander D; Hawkins M; Lalloo F; Green K; Lee TJ; Walker J; Matthews G; Rutherford T; Sasieni P; Monahan KJ
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37668669
[TBL] [Abstract][Full Text] [Related]
13. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs.
Arasaradnam RP; Bhala N; Evans C; Greenaway J; Logan R; Penman I; Seward E; Singh B; Smith S; Stephenson JA; Waugh N;
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):717-719. PubMed ID: 32526209
[No Abstract] [Full Text] [Related]
14. The increasing burden of the 2-week wait colorectal cancer pathway in a single centre: the impact of faecal immunochemical tests.
Farkas N; O'Brien JW; Palyvos L; Maclean W; Benton S; Rockall T; Jourdan I
Ann R Coll Surg Engl; 2024 Apr; 106(4):338-343. PubMed ID: 36688865
[TBL] [Abstract][Full Text] [Related]
15. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.
von Wagner C; Stoffel S; Freeman M; Laszlo H; Nicholson BD; Sheringham J; Szinay D; Hirst Y
Br J Gen Pract; 2018 Nov; 68(676):e757-e764. PubMed ID: 30297435
[TBL] [Abstract][Full Text] [Related]
16. Adapting the investigation of patients on urgent suspected cancer pathway with lower gastrointestinal symptoms across Wales during COVID-19.
Tang A; Chandler S; Torkington J; Harris DA; Dhruva Rao PK
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S35-S41. PubMed ID: 35616545
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy.
Kearsey CC; Graham C; Lobb HS; Chacko J; Weatherburn R; Rooney PS
BMC Fam Pract; 2021 May; 22(1):90. PubMed ID: 33980161
[TBL] [Abstract][Full Text] [Related]
18. Impact of faecal haemoglobin based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis.
Delson D; Ward M; Haddock R; Nobes J; Digby J; Strachan JA; Mowat C
Colorectal Dis; 2023 Apr; 25(4):787-793. PubMed ID: 36495081
[TBL] [Abstract][Full Text] [Related]
19. Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage and prioritisation pathway for patients with colorectal symptoms.
Falvey J; Frampton CMA; Gearry RB; Hudson B; Whiteley L
N Z Med J; 2023 Jul; 136(1578):55-76. PubMed ID: 37414077
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England.
Hunt N; Rao C; Logan R; Chandrabalan V; Oakey J; Ainsworth C; Smith N; Banerjee S; Myers M
BMJ Open; 2022 Apr; 12(4):e059940. PubMed ID: 35418441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
